156 related articles for article (PubMed ID: 18270432)
1. The -1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects.
Tokunaga A; Miura A; Okauchi Y; Segawa K; Fukuhara A; Okita K; Takahashi M; Funahashi T; Miyagawa J; Shimomura I; Yamagata K
Endocr J; 2008 Mar; 55(1):205-12. PubMed ID: 18270432
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic insights into the link between visfatin gene C-1535T polymorphism and coronary artery disease: an in vitro study.
Wang YS; Gao W; Li HF; Wang ZM; Zhu J; Zhao H; Yan JJ; Jia EZ; Yang ZJ; Wang LS
Mol Cell Biochem; 2012 Apr; 363(1-2):315-22. PubMed ID: 22147201
[TBL] [Abstract][Full Text] [Related]
3. Correlation between polymorphisms in the visfatin gene and its expression in the serum and coronary artery calcification.
Jin LW; Zheng SB; Zhou ZH; Pan SF; Zheng Y
Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421003
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.
Böttcher Y; Teupser D; Enigk B; Berndt J; Klöting N; Schön MR; Thiery J; Blüher M; Stumvoll M; Kovacs P
J Clin Endocrinol Metab; 2006 Jul; 91(7):2725-31. PubMed ID: 16636125
[TBL] [Abstract][Full Text] [Related]
5. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.
Jian WX; Luo TH; Gu YY; Zhang HL; Zheng S; Dai M; Han JF; Zhao Y; Li G; Luo M
Diabet Med; 2006 Sep; 23(9):967-73. PubMed ID: 16922702
[TBL] [Abstract][Full Text] [Related]
6. In-vitro function of upstream visfatin polymorphisms that are associated with adverse cardiometabolic parameters in obese children.
Ooi DS; Ong SG; Heng CK; Loke KY; Lee YS
BMC Genomics; 2016 Nov; 17(1):974. PubMed ID: 27887573
[TBL] [Abstract][Full Text] [Related]
7. Genetic variant in visfatin gene promoter is associated with decreased risk of coronary artery disease in a Chinese population.
Yan JJ; Tang NP; Tang JJ; Jia EZ; Wang MW; Wang QM; Zhu J; Yang ZJ; Wang LS; Huang J
Clin Chim Acta; 2010 Jan; 411(1-2):26-30. PubMed ID: 19804767
[TBL] [Abstract][Full Text] [Related]
8. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients.
Mirzaei K; Hossein-Nezhad A; Javad Hosseinzadeh-Attar M; Jafari N; Najmafshar A; Mohammadzadeh N; Larijani B
Minerva Endocrinol; 2009 Dec; 34(4):273-9. PubMed ID: 20046156
[TBL] [Abstract][Full Text] [Related]
9. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children.
Ooi SQ; Chan RM; Poh LK; Loke KY; Heng CK; Chan YH; Gan SU; Lee KO; Lee YS
Pediatr Obes; 2014 Apr; 9(2):81-91. PubMed ID: 23447513
[TBL] [Abstract][Full Text] [Related]
10. A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes.
Zhang YY; Gottardo L; Thompson R; Powers C; Nolan D; Duffy J; Marescotti MC; Avogaro A; Doria A
Obesity (Silver Spring); 2006 Dec; 14(12):2119-26. PubMed ID: 17189536
[TBL] [Abstract][Full Text] [Related]
11. The common -55 C/T polymorphism in the promoter region of the uncoupling protein 3 gene reduces prevalence of obesity and elevates serum high-density lipoprotein cholesterol levels in the general Japanese population.
Hamada T; Kotani K; Fujiwara S; Sano Y; Domichi M; Tsuzaki K; Sakane N
Metabolism; 2008 Mar; 57(3):410-5. PubMed ID: 18249216
[TBL] [Abstract][Full Text] [Related]
12. Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain.
Martínez Larrad MT; Corbatón Anchuelo A; Fernández Pérez C; Pérez Barba M; Lazcano Redondo Y; Serrano Ríos M;
PLoS One; 2016; 11(5):e0153976. PubMed ID: 27166797
[TBL] [Abstract][Full Text] [Related]
13. Plasma visfatin, associated with a genetic polymorphism -1535C>T, is correlated with C-reactive protein in Chinese Han patients with traumatic brain injury.
Weng JF; Chen J; Hong WC; Luo LF; Yu W; Luo SD
Peptides; 2013 Feb; 40():8-12. PubMed ID: 23270673
[TBL] [Abstract][Full Text] [Related]
14. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population.
Bailey SD; Loredo-Osti JC; Lepage P; Faith J; Fontaine J; Desbiens KM; Hudson TJ; Bouchard C; Gaudet D; Pérusse L; Vohl MC; Engert JC
Diabetes; 2006 Oct; 55(10):2896-902. PubMed ID: 17003359
[TBL] [Abstract][Full Text] [Related]
15. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
[TBL] [Abstract][Full Text] [Related]
16. Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population.
Zhai G; Wen P; Guo L; Chen L
Clin Chem Lab Med; 2006; 44(11):1313-6. PubMed ID: 17087641
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic variability in selected regions in visfatin (NAMPT) gene with anthropometric parameters and dietary composition in obese and non-obese Central-European population.
Stastny J; Bienertova-Vasku J; Tomandl J; Tomandlova M; Zlamal F; Forejt M; Splichal Z; Vasku A
Diabetes Metab Syndr; 2013; 7(3):166-71. PubMed ID: 23953183
[TBL] [Abstract][Full Text] [Related]
18. A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia.
Björn Lundahl ; Leren TP; Ose L; Hamsten A; Karpe F
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1784-8. PubMed ID: 10894817
[TBL] [Abstract][Full Text] [Related]
19. The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity.
Belo VA; Luizon MR; Lacchini R; Miranda JA; Lanna CM; Souza-Costa DC; Tanus-Santos JE
Int J Obes (Lond); 2015 Jan; 39(1):130-5. PubMed ID: 24100423
[TBL] [Abstract][Full Text] [Related]
20. Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy.
Luizon MR; Belo VA; Palei AC; Amaral LM; Lacchini R; Sandrim VC; Duarte G; Cavalli RC; Tanus-Santos JE
Hypertens Res; 2015 May; 38(5):361-6. PubMed ID: 25716650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
